<?xml version="1.0"?>
<nitf version="-//IPTC//DTD NITF 3.4 GLOBENEWSWIRE//EN" change.time="19:30" change.date="October 18, 2006">
  <head>
    <title>Arla Foods Ingredients Targets GLP-1 Companion Nutrition at Vitafoods Europe</title>
    <meta name="issuer-name" content="Arla Foods Ingredients" />
    <meta name="issuer-isin" content="" />
    <meta name="issuer-industry" content="Food Products" />
    <meta name="issuer-city" content="Viby J" />
    <meta name="issuer-state" content="Aarhus" />
    <meta name="issuer-postalcode" content="8260" />
    <meta name="issuer-country" content="DK" />
    <meta name="article-headline" content="Arla Foods Ingredients Targets GLP-1 Companion Nutrition at Vitafoods Europe" />
    <meta name="article-subheadline" content="" />
    <meta name="article-id" content="9690142" />
    <meta name="article-revision" content="0" />
    <meta name="article-pubdate" content="2026-04-14T19:33:56-0700" />
    <meta name="article-language" content="en" />
    <meta name="article-keywords" content="Arla Foods Ingredients,GLP-1" />
    <meta name="article-content" content="Product / Services Announcement" />
    <docdata>
      <doc-id id-string="9690142" regsrc="GlobeNewswire" />
      <date.issue norm="20260415T023356Z" />
      <doc.copyright holder="GlobeNewswire, Inc." year="2026" />
    </docdata>
  </head>
  <body>
    <body.head>
      <hedline>
        <hl1>Arla Foods Ingredients Targets GLP-1 Companion Nutrition at Vitafoods Europe</hl1>
      </hedline>
      <distributor>GlobeNewswire</distributor>
      <dateline>
        <story.date>April 15, 2026</story.date>
      </dateline>
    </body.head>
    <body.content>
      <link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"/><p>COPENHAGEN, Denmark, April  14, 2026  (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=yrsT8w-8PIMUfQnpsqz1qvdDtKh83mq2d6W0cMTiRuKviPGhX1K9TooNjjw3hPMTvTVbLM6_2ZxOC0oDJWV0SREdWc3IyXA3SuzcShLR5SDvaH8ugbERgs6rcwwW7Tk1" rel="nofollow" target="_blank">Arla Foods Ingredients</a> has developed high-protein, nutrient-dense application concepts for users of GLP-1 anti-obesity medications, which it will showcase at Vitafoods Europe (5<sup>th</sup>-7<sup>th</sup> May 2026 in Barcelona).</p>    <p>Originally developed to treat diabetes, GLP-1 receptor agonists have re-shaped the weight management market. In 2025, 11% of consumers globally <a href="https://www.globenewswire.com/Tracker?data=YxC7kpzoRB5TDTfHu963sPpzgPwSR6qEMUl_onzezBk2tDdZv1aOP-gL3Jr9Aa6KHDdEVOYx5wNQESIYWuOPeFszxLQ8T3XyZNmoof-2XO2DhHfVbY8_YtFGnIZfY9tjxFgp_kQsOmu0x9PenMWYZbem3eBGBPRx92Jep-P7EHk=" rel="nofollow" target="_blank">[1]</a> and 18% in the US <a href="https://www.globenewswire.com/Tracker?data=fxA9yS6u7l3tQyRtYvGDKbn5CFV8jL9njmFkpnK4PupsEvefbh_VN7B7-I52rVDHur9qpYDQbViriY2mTT0No15PBEqtuNgyRODEgd9Ed99BvMzicq4T8z7AAhXKP4ugFsPAJYfCXoEn14jjzBG3FMuY7ncrvxML2Wf_ZO0W5ms=" rel="nofollow" target="_blank">[2]</a> who were actively trying to lose weight reported using them, with uptake expected to rise as availability expands, tablet formats emerge and prices fall <a href="https://www.globenewswire.com/Tracker?data=GLaKRZvdLV0BJj8dUl52SLu_o4D10jrfHJi9oTo-swv_eajkkNiBowemzupn8NFNNBMQ77sJlODywQDfsNeHaIW9aLHPC5hsK9N1VgYcQWz7I3kXlD40rIpdQhHnJjhEdpH8wi2WUb6gKFqOhbpqt5OuKX2TgsH3MP6_yiEfbDQ=" rel="nofollow" target="_blank">[3]</a>.</p>    <p>However, GLP-1 use is associated with side effects: lean muscle loss may reach 40% of total mass lost, versus around 25% with traditional interventions [<a href="https://www.globenewswire.com/Tracker?data=qwJjyDQnfvQL4u785fSst-6unt4ev58mv4nwfuIjkn9lniLh22cd9yHGXmXYHvvVyLfzfJctOZuCMO75qZPI16-gh0GviNS-c6AakGBVmlo=" rel="nofollow" target="_blank">4</a>, <a href="https://www.globenewswire.com/Tracker?data=LUfn1uZK7_fdELnVCIPThcemLrMK9_ITSjSF9WfBb5uAD6IhlDSv6_g9X5TBorEWzzJxRgOcTxfJPz7_0VV_6jbNZhc6b--JPWGQJQue9AQ=" rel="nofollow" target="_blank">5</a>, <a href="https://www.globenewswire.com/Tracker?data=zYirwrexjJWmx4NRTaxinEQxrHcDsu4dpqJecBmhWft3xEqD7lfvgAQgxw8WevBWXsxMp8ol4AmBGWFDHl0FkwS_ZR-gHZTbtsJjCaxK_EQ=" rel="nofollow" target="_blank">6</a>], while up to 76% of GLP-1 consumers report gastric discomfort and reduced appetite <a href="https://www.globenewswire.com/Tracker?data=iS0qkzfhR0wj2IxaO2empBr4Em5aPCI5TE3npGGPdQJwpiE0Na2_IYiFdhWhCvPZHNRPWwPlvjWSbDrKbkuoQw==" rel="nofollow" target="_blank">[7]</a>.</p>    <p>To help manufacturers address these needs, Arla Foods Ingredients has developed high-protein concepts with Nutrilac<sup>®</sup> and Lacprodan<sup>®</sup> BLG-100, delivering all essential amino acids for muscle health in nutrient-dense formats, and incorporating probiotics / cultures from Novonesis to support digestive well-being.  </p>    <p>The range includes great-tasting formats for reduced appetites: </p>    <ul type="disc"><li>A fermented, high-protein shot featuring Nutrilac<sup>®</sup> ProteinBoost, offering 10g of protein per 70ml serving; low fat, lactose-reduced and no added sugar.<br /><br /></li><li>A fermented, high-protein drinking yoghurt featuring Nutrilac<sup>®</sup> ProteinBoost and Nutrilac<sup>®</sup> MFGM, providing 20g protein per 200ml serving; lactose-reduced.<br /><br /></li><li>A fermented, high-protein spoonable yoghurt featuring Nutrilac<sup>®</sup> ProteinBoost, Nutrilac<sup>®</sup> YO-7700, and Capolac<sup>®</sup> milk minerals, providing 20g protein per 120g serving; high in calcium, low fat and lactose-reduced.<br /><br /></li><li>A high-protein water-based shot for ambient storage, featuring Lacprodan<sup>®</sup> BLG-100 and providing 21g of protein per 100ml serving; fat-free, sugar-free and low in lactose.<br /><br /></li></ul>    <p>Anne Widart, Chief Commercial Officer of Arla Foods Ingredients, said: “Nutrition for GLP-1 users is a growing category, creating opportunities for dairy manufacturers. There is increasing demand for nutrient-dense, high-protein products in formats suited to smaller appetites. Our concepts are designed to help manufacturers respond to these evolving needs.”</p>    <p>Arla Foods Ingredients will showcase the GLP-1 companion nutrition solutions at Vitafoods Europe (Stand #3G156) alongside two additional concepts:</p>    <ul type="disc"><li>An aerated protein bar solution made with Nutrilac<sup>®</sup> PB-8420, offering high-quality milk protein and a light, soft texture enabled by stable air incorporation during processing and shelf life.<br /><br /></li><li>Ready-to-stir medical nutrition powder solutions made with Lacprodan<sup>®</sup> BLG-100 Acidic, combining a refreshing taste, no bitterness and low astringency, low viscosity at high protein levels, and good solubility in water, foods and drinks.<br /><br /></li></ul>    <p>Photo <a href="https://www.globenewswire.com/Tracker?data=HLG1ZxAcZIKefQW9_cKmbvtFSuxD8rB3rN5--dCHahiBUjwk5Te3xUKzk4N-VijpEr97m1b8k9w2QRDqm43jWrSKLjCaYJJI0w3cz92yLg08pT8xaKHRHECh3DVdzXczi9imFNKGwxeRhzk69necgxDZKbp50_mac6okM6lU1Qkzr-DoZlDLkl8z1KCfplxrtstRoEzfzK7sUaZlSquHjPw70aMaLPOElhlGxIh1BkiHP6TsjIZut12ZQg-0yK8zSNJW1oxBBELTOxs7nYbB3A==" rel="nofollow" target="_blank">https://www.globenewswire.com/NewsRoom/AttachmentNg/debb0da5-3fc7-43ee-93f7-b975d7eab6b0</a></p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTY5MDE0MiM3NTM0MTU2IzUwMDExOTMxOQ==" /> <br /><img alt="" src="https://ml.globenewswire.com/media/ZjAyMGMyNDctODY1Ni00YTgyLTllYjgtZWRiZWY1ZjFkZjVlLTUwMDExOTMxOS0yMDI2LTA0LTE1LWVu/tiny/Arla-Foods-Ingredients.png" referrerpolicy="no-referrer-when-downgrade" /><pre>Media contact: hz@ispiderpr.com</pre><p><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/8bd74729-7383-474e-b17e-10a54b9d62db"><img src="https://ml.globenewswire.com/media/8bd74729-7383-474e-b17e-10a54b9d62db/small/arla-logo-png.png" border="0" width="150" height="29" alt="Primary Logo" /></a></p>
    </body.content>
  </body>
</nitf>